sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet
- RxCUI
- 1939329
- RxNorm name
- sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet
- Display name
- sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet
- Full name
- sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vosevi | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | Gilead Sciences, Inc. | 17ffc094-8ca7-45d2-80d8-fd043bc9a221 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 1939329 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 17ffc094-8ca7-45d2-80d8-fd043bc9a221 | sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [PSN] · sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [SCD] | 2 | 6 | These highlights do not include all the information needed to use VOSEVI safely and effectively. See full prescribing information for VOSEVI. VOSEVI ® (sofosbuvir, velpatasvir, and voxilaprevir) tablets, for oral use Initial U.S. Approval: 2017 | 20250714 |